Article
Future Directions in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
25 Jul 2025
Abstract excerpt
BACKGROUND: Allogeneic stem cell transplantation (ASCT) has been a cornerstone of acute lymphoblastic leukemia (ALL) treatment for decades, with significant improvements in patient survival. These advancements are linked to better therapies, refined conditioning regimens, and minimal residual disease monitoring. Despite progress, challenges remain in reducing relapse, treatment-related mortality, and toxicity....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
